Search results
Results from the WOW.Com Content Network
Limb–girdle muscular dystrophy (LGMD) is a genetically heterogeneous group of rare muscular dystrophies that share a set of clinical characteristics. [7] It is characterised by progressive muscle wasting which affects predominantly hip and shoulder muscles. [ 8 ]
LAMA2 muscular dystrophy; Other names: Congenital muscular dystrophy type 1A (MDC1A) or Merosin-deficient congenital muscular dystrophy, Late-onset LAMA2 muscular dystrophy or limb girdle muscular dystrophy 23 (LGMDR23), Laminin subunit alpha-2 muscular dystrophy. Diagrammatic illustration of laminin-211 or Laminin-alpha2 chain.
Calpainopathy is the most common type of autosomal recessive limb-girdle muscular dystrophy (LGMD). [2] It preferentially affects the muscles of the hip girdle and shoulder girdle. No disease modifying pharmaceuticals have been developed as of 2019, although physical therapy, lifestyle modification, and orthopedic surgery can address symptoms.
Bethlem myopathy is predominantly an autosomal dominant myopathy, classified as a congenital form of limb-girdle muscular dystrophy. [2] There are two types of Bethlem myopathy, based on which type of collagen is affected. [3] Bethlem myopathy 1 (BTHLM1) is caused by a mutation in one of the three genes coding for type VI collagen.
Glycogen storage disease type II (GSD-II), also called Pompe disease, and formerly known as GSD-IIa or Limb–girdle muscular dystrophy 2V, is an autosomal recessive metabolic disorder [1] which damages muscle and nerve cells throughout the body.
limb-girdle muscular dystrophy type 2B. [9] Distal myopathy with anterior tibial onset (DMAT) [10] [11] 606768: DMAT can be considered a variant of Miyoshi. Early adult-onset type 3 [4] Laing (Gower) AD [5] 160500: MYH7 [5] 14q11.2 AD = autosomal dominant; AR = autosomal recessive
A 38-year-old Pennsylvania woman credits a dating app focused on the disabled and chronically ill communities with helping her “find love.” Tina Fegley, who has a form of Limb-girdle muscular ...
The sarcoglycanopathies are a collection of diseases resulting from mutations in any of the five sarcoglycan genes: α, β, γ, δ or ε. The five sarcoglycanopathies are: α-sarcoglycanopathy, LGMD2D; β-sarcoglycanopathy, LGMD2E; γ-sarcoglycanopathy, LGMD2C; δ-sarcoglycanopathy, LGMD2F and ε-sarcoglycanopathy, myoclonic dystonia.